Skip to content

Effectiveness and adverse effects in reducing nasal symptoms in patients with allergic rhinitis by using herbal steam inhalation

Effectiveness and Adverse Effects of Herbal Steam Inhalation in Reducing Nasal Symptoms in Patients with Allergic Rhinitis

Status
Unknown
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250707014
Enrollment
68
Registered
2025-07-07
Start date
2025-07-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis Allergic Rhinitis

Interventions

Fresh Herbal Ingredients (7 types) consist of 50 grams of lemongrass (Cymbopogon citratus) 50 grams of kaffir lime fruit (Citrus hystrix) 10 grams of shallot (Allium cepa var. aggregatum) 10 grams of
Experimental Drug,Placebo Comparator No treatment

Sponsors

Faculty of Medicine, Thammasat University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 60 years old. 2. Exhibiting clear symptoms with at least two nasal symptoms present bilaterally, occurring for at least one hour on most days, and persisting for at least one year, classified as mild to moderate severity according to the Thai Clinical Practice Guidelines for Allergic Rhinitis (Revised 2022). 3. Having a history of allergic rhinitis diseases. 4. No continuous use of anti-allergy medication or nasal sprays for at least 2 months prior to the study. 5.Able to read and write, as participants will be required to complete questionnaires during the study.

Exclusion criteria

Exclusion criteria: 1. Presence of nasal obstruction preventing inhalation of the herbal steam. 2. Pregnant or breastfeeding women. 3. Fever or body temperature higher than 37.5 degree celsius. 4. Experiencing dizziness. 5. Having skin inflammation. 6. History of allergy to herbs, steam, or heat. 7. History of the following chronic diseases: severe asthma or chronic obstructive pulmonary disease (COPD). 8. Blood pressure higher than 140/90 mmHg or lower than 90/60 mmHg. 9. Presence of open wounds on the face.

Design outcomes

Primary

MeasureTime frame
visual analog scale Before After 0-10

Secondary

MeasureTime frame
Acoustic rhinometry before after Measurements will focus on the minimal cross-sectional area (MCA) and nasal cavity volume, Total nasal symptom score (TNSS) before after 0-3,Adverse Event after Monitored through patient self-report diaries and clinical observation for any signs of irritation, allergic reaction, or other side effects during and after the treatment period.,Patient Satisfaction after Likert scale questionnaire ranging from 1 (very dissatisfied) to 5 (very satisfied) after the intervention.

Countries

Thailand

Contacts

Public ContactNichamon Mukkasombut

Thammasat University

nschamon@tu.ac.th0844369639

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026